Why Google Disapproved Your Healthcare Ads

Your clinic ads ran for three weeks. Monday morning, every ad in the account is disapproved. You rewrite the headlines, strip the word 'treatment', resubmit, and wait. Nothing changes.

That is the tell. Two different Google policies disapprove healthcare ads, and they need opposite fixes. One is about what you say. The other is about who you target — and no rewrite on earth repairs a targeting violation.

Why was your healthcare ad disapproved — copy or audience?

There are two policies doing the disapproving, and the fix for one never fixes the other. Healthcare and medicines is about your service, your landing page and your keywords. Personalized advertising is about the audiences attached to your campaign. Open the disapproval and read the policy name, not the ad.

Google says most ads are reviewed within one business day (Google Ads Help). So if you edit the copy, resubmit, and get the same disapproval back the next morning, you did not fix the thing that was broken. You confirmed it.

That last row traps a lot of owners. Eligible (limited) means the ad “can run but will be restricted on where it can serve.” Google also warns the label can apply “if your website content contains terms associated with regulated industries, even if your products or services themselves are compliant” (Google Ads policy help). A cosmetic dermatology practice can get labeled because a blog post on its own site mentions a prescription drug.

What does Google's Healthcare and Medicines policy actually restrict?

It is a list of 13 named areas, not a blanket rule on health: prescription drug services, restricted drug terms, pharmaceutical manufacturers, unauthorized pharmacies, unapproved substances, prescription opioid painkillers, speculative and experimental treatments (including cell and gene therapies), clinical trial recruitment, addiction services, abortion, birth control and fertility, HIV home tests, and health insurance (Google Ads Healthcare and medicines policy).

Read that list again and notice who is not on it. A dentist. A chiropractor. A physical therapist. An urgent care clinic. A dermatologist doing cosmetic work. If that is you, this policy is not your problem, and any agency telling you it is has not read it.

Two entries are worth fearing. Unauthorized pharmacies and prescription opioid painkillers carry Google's “egregious violation” language: “your Google Ads accounts will be suspended upon detection and without prior warning, and you will not be allowed to advertise with Google Ads again.” There is no warning shot. If your site sells anything that could read as prescription drugs without a prescription, deal with that before you spend another dollar.

The quieter one is restricted drug terms. Google's baseline rule is that it restricts prescription drug terms in ads, landing pages and keywords — but the United States gets a carve-out most agencies miss. For campaigns targeting the US, Canada or New Zealand, Google states: “While you don't need to be certified in order to use prescription drug terms in ads and landing pages, you must be certified in order to keyword-target these terms” (Restricted drug terms). So the drug name on your landing page is legal. Bidding on it is the part that needs certification.

Which healthcare advertisers need certification, and how long does it take?

In the United States, four things need certification: online pharmacies, telemedicine providers that facilitate prescribing, recovery-oriented drug and alcohol addiction services, and health insurance. The first three route through LegitScript; health insurance routes through G2RS. And in every case, Google's own line is that “advertisers must also be certified with Google” — the third-party certification is a prerequisite, not the finish line.

Nobody publishes an end-to-end timeline. Google does not state how long healthcare certification review takes, and neither does LegitScript. The only timing commitment either one makes is LegitScript's expedite fee: an extra $2,500 per application to have the review started within 2 business days of submission. Started. Not finished.

Standard LegitScript healthcare certification is $975 per website to apply (nonrefundable, win or lose) plus a $2,150 annual certification fee — $3,125 in year one, per domain (LegitScript pricing). If a marketing agency quotes you a launch date for a telehealth account and does not mention that number, they have never done one.

The trap that catches med spas: LegitScript names medical aesthetic treatments involving licensed healthcare professionals — injectables, dermal fillers, hormone therapy, weight loss, prescription-strength skin care — as certification-triggering. The moment your aesthetics business prescribes anything through a telehealth flow, you are a telemedicine advertiser in Google's eyes. Our med spa marketing playbook covers the claims side; the LegitScript gate for treatment centers covers the addiction-services path.

Why can't you remarket to people who visited a treatment page?

Because Google classifies Health as a sensitive interest category, and advertisers promoting sensitive interest categories “are unable to use advertiser-curated audiences” — full stop. That is four tools gone: Customer Match, your data segments (the old remarketing lists), lookalike segments, and audience expansion (Google's personalized advertising policy).

This is the disapproval owners never see coming, because the remarketing plan is the thing every agency pitches to a clinic. It cannot be delivered. Not badly — at all.

And Google's definition of Health is wider than most clinics assume. It covers physical or mental health conditions, chronic conditions and the products used to manage them, “any health issues associated with intimate body parts or functions,” and “invasive medical procedures, including cosmetic surgery, surgical procedures, or injections.” Google's own examples include counseling for depression, anxiety and addiction, treatments for pregnancy and infertility, and CPAP machines for sleep apnea (Health in personalized advertising).

Read that as an operator. An injectables page is health content. A fertility page is health content. A therapy-for-anxiety page is health content. Which means the retargeting list you built from those page views is unusable, and the patient email list you were about to upload to Customer Match is unusable too. General retargeting still works fine for unregulated service businesses — see our retargeting guide — but the health carve-out is real and it is absolute.

One more landmine: Google notes that Demand Gen campaigns “use advertiser-curated audiences by default and may be restricted from serving” in sensitive interest categories. If someone launched Demand Gen for your clinic and the spend went nowhere, that is why.

What targeting is left once health conditions are off the table?

Seven targeting types stay open — every audience Google builds itself, because Google strips the sensitive signals out of them before you ever touch them. What you lose is the audiences you build.

The catch on custom segments is buried in a footnote and it matters: custom segments “using sensitive creative assets or pointing to sensitive landing pages will only serve with Display campaigns to non-sensitive audiences or contextually. All other campaigns using Custom Segment audiences with sensitive creative assets or landing pages will not be eligible to serve.” So a custom segment pointed at your treatment page is a Display-only tool, and only barely.

The honest verdict: for a regulated clinic, search intent plus tight geography plus a landing page that converts is the whole program. Audience layers were never doing the work an agency deck claimed they were. Someone typing “dermatologist near me open saturday” has already told you everything a remarketing list would have guessed at.

What we would run instead: exact-match and phrase-match search on symptom-free service terms, radius targeting around each location, call-only ads for urgent intent, and contextual Display if you want any upper-funnel at all. Watch one trap here — the 1 km minimum radius rule and the ZIP-code ban belong to the Access to opportunities categories (housing, employment, consumer finance), not to health. Agencies conflate those two policies constantly. Your clinic can still target ZIP codes.

How do you appeal a disapproval without getting the account flagged?

Each ad gets three appeals, total. Appeal an ad unsuccessfully three times and you cannot appeal it again until you contact support (Google's appeal guidance). Treat appeals like a limited resource, because they are one.

The other rules Google states plainly: wait at least 24 hours between appeals on the same ads or they get marked as duplicates; submit too many unique appeals inside a 24-hour window and Google “may suspend processing of additional appeals during that window”; and if you appeal all the ads in an account at once, “the review may take longer to be completed.”

The trick nobody tells you is in the same document. If you have genuinely fixed the issue but the appeal fails or comes back as a duplicate, Google says: “don't repeatedly submit appeals. Instead, make a minor edit to your ad's text or final URL and save it to force the system to perform a new crawl.” That is a re-crawl, not an appeal. It does not burn one of your three.

• Appeal only when you can name the specific policy line you believe was misapplied.
• Choose 'Dispute decision' when the label is wrong; choose 'Made changes to comply' when you fixed something.
• Never appeal a Healthcare and medicines disapproval you have not certified for — you will lose three times and get nowhere.
• Never appeal a Personalized advertising disapproval at all. Delete the audience. There is nothing to dispute.
• Do appeal a wrongly applied Eligible (limited) label — Google explicitly lists that as an appealable case.

Why the discipline matters: Google enforces with “a combination of Google AI and human evaluation,” takes “repeat violations of our policies seriously,” and runs “a strike system for repeat offenders” (Google Ads policies). Spraying appeals at a violation you have not fixed is not persistence. It is a paper trail against your account.

What compliant ad copy looks like for a regulated clinic

Three things kill clinic copy: drug keywords, outcome claims, and missing licensing details. Fix those three and most healthcare accounts run clean.

• Drug names: in the US you may name a prescription drug in ad copy and on the landing page without certification — but you cannot keyword-target that term until Google certifies you. Bid on 'physician-supervised weight management', not on the molecule.
• Outcome claims: Google's Misrepresentation policy names “misleading or unrealistic claims regarding weight loss” as an example of what gets you disapproved. Drop the pounds-lost numbers and the before/after promises.
• Licensing and contact details: the same policy names “failing to display tax or licence numbers, contact information, or physical address where relevant.” Put the license number, a real address and a real phone number in the site footer.
• Products that imply drug strength: the Unapproved substances policy bans products “that imply they're as effective as prescription drugs.” That supplement page can disapprove your whole account's ads.
• Editorial basics: Google calls out “gimmicky use of words, numbers, letters, punctuation, or symbols such as FREE, f-r-e-e.” Yes, this still catches people in 2026.

The pattern that survives review is boring and it converts: name the service, name the city, name the credential, name the next step. “Board-certified dermatologist in Tempe. Same-week appointments. Most PPO plans accepted.” No condition targeting, no promise, no drug name — and a person searching for a dermatologist knows exactly what they are clicking.

How do you prove ad spend works when the audience tools are restricted?

You measure the booked appointment, not the click — and you answer the phone fast. In a 2011 Harvard Business Review study, firms that contacted an online lead within an hour were nearly seven times as likely to qualify that lead (defined as a meaningful conversation with a key decision maker) as firms that waited just one hour longer, and more than 60 times as likely as firms that waited 24 hours or more. The same research audited 2,241 US companies and found the average response time to a web lead was 42 hours, with 23% never responding at all (HBR, 2011).

For a clinic with no remarketing safety net, that is the whole ballgame. Every dollar buys one shot at one click, and the front desk either converts it in the first hour or it is gone to the practice down the road.

So the measurement stack is: call tracking on every ad-driven call, a conversion that fires on a kept appointment rather than a form fill, and offline conversion import feeding that back into Smart Bidding. Keep it clean — Google's own data rules bar running ads that “collect or contain personally identifiable information” and bar using PII “in connection with any anonymous or pseudonymous information, including in your data segments.” Measure with click IDs. Never turn patient data into an audience.

Then hold the channel to a number. We run a 90-day kill switch: if a channel has not produced qualified leads in 90 days, it gets cut, not defended. In a category where you cannot retarget and certification can cost $3,125 before launch, a channel that cannot show booked patients inside a quarter is not underperforming. It is finished.

If your clinic's ads are stuck in a disapproval loop, the first job is diagnostic: which policy, which asset, which audience. That is what our paid ads service starts with, and it is what a proper free audit tells you before you sign anything. Month to month, no lock-in, and you keep the ad account either way. Get my free audit.